CardioOne · 3 weeks ago
Nuclear Medicine Technologist (Per Diem or FT)
CardioOne is a company that partners with independent cardiologists to enhance patient outcomes through innovative solutions. They are seeking a motivated Nuclear Medicine Technologist to perform nuclear stress testing and collaborate with healthcare professionals to ensure quality patient care in Nuclear Cardiology.
Health CareMedicalWellness
Responsibilities
Performs Nuclear stress testing, calibrations and quality control procedures
Organizes the nuclear stress schedule. Responsible for maintenance and ordering of nuclear equipment and supplies
Produces accurate floods on cameras and diagnostic images for interpretation
Participates in updating and developing all policies and procedures for nuclear cardiology testing. Participates in the orientation of new employees as needed
Maintains all isotope records and properly disposes radioactive waste
Participates in cleaning the area before, during and after procedures. Ensures area is safe. Reports abnormal calibrations or images
Assist with nuclear accreditation
Performs other duties as assigned
Engages as needed with the Practice Leadership to help develop and modify efficiencies as needed
Qualification
Required
Graduate of a program in Nuclear Medicine Technology required
Licensure in the state of NH required
American Registry of Radiologic Technologists (ARRT) Registered or Nuclear Medicine Technology Certification Board (NMTCB) Certified required
Basic Life Support (BLS) certification is required
Excellent communication (both oral and written), interpersonal, and organization skills
Excellent computer skills (Microsoft Office)
Full working knowledge of Nuclear Medicine equipment and Radiation Physics
Preferred
1-2 years' experience is preferred
Experience with Cardiac SPECT and PET is strongly preferred
ACLS preferred
Benefits
Medical
Dental
Vision
401k plan w/match
PTO (Personal Time Off)
Sick time
Company
CardioOne
CardioOne is a physician-centric partner that helps independent cardiology practices reach their full potential.
Funding
Current Stage
Growth StageTotal Funding
$8M2024-03-04Acquired
2023-09-18Seed· $8M
Recent News
2025-04-28
2025-04-25
Company data provided by crunchbase